Merit Medical Systems | MMSI

Peers Price Chg Day Year Date
4543 Terumo 2,608.50 15.50 0.60% -34.71% Apr/26
7733 Olympus 2,173.50 -13.00 -0.59% -7.08% Apr/26
ABT Abbott 106.90 -0.06 -0.06% -1.70% Apr/25
ATRC AtriCure 22.61 -0.41 -1.78% -46.49% Apr/25
BAX Baxter International 40.25 -0.73 -1.78% -12.65% Apr/25
BDX Becton, Dickinson and Co. 230.77 -3.18 -1.36% -10.73% Apr/25
BSX Boston Scientific 73.27 0.42 0.58% 43.39% Apr/25
COO Cooper Companies 89.90 -0.35 -0.38% -5.12% Apr/25
DXCM Dexcom 138.02 0.04 0.03% 10.48% Apr/25
EW Edwards Lifesciences 87.89 -0.84 -0.94% 0.54% Apr/25
GMED Globus Medical 50.37 -1.07 -2.08% -12.64% Apr/25
HAE Haemonetics 87.66 1.44 1.67% 6.47% Apr/25
HOLX Hologic 75.71 -1.07 -1.39% -10.84% Apr/25
IART Integra LifeSciences 28.43 -0.95 -3.23% -47.55% Apr/25
ICUI ICU Medical 94.49 -2.23 -2.31% -47.84% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
MMM 3M 91.39 -0.62 -0.67% -11.20% Apr/25
MMSI Merit Medical Systems 73.39 -0.64 -0.86% -5.51% Apr/25
PFE Pfizer 25.26 -0.97 -3.69% -34.61% Apr/25
PODD Insulet 164.03 -3.20 -1.91% -48.20% Apr/25
STAA STAAR Surgical 46.89 -0.93 -1.94% -30.64% Apr/25
SYK Stryker 336.85 -0.45 -0.13% 12.73% Apr/25
TFX Teleflex 206.12 -5.36 -2.53% -23.19% Apr/25
TNDM Tandem Diabetes Care 35.56 0.44 1.25% -5.17% Apr/25
ZBH Zimmer Biomet Holdings 119.52 -1.64 -1.35% -14.06% Apr/25

Indexes Price Day Year Date
CCMP USND 15612 -100.99 -0.64% 31.70% Apr/25
RTY US2000 1981 -14.31 -0.72% 13.13% Apr/26

Merit Medical Systems traded at $73.39 this Thursday April 25th, decreasing $0.64 or 0.86 percent since the previous trading session. Looking back, over the last four weeks, Merit Medical Systems lost 0.66 percent. Over the last 12 months, its price fell by 5.51 percent. Looking ahead, we forecast Merit Medical Systems to be priced at 74.30 by the end of this quarter and at 70.13 in one year, according to Trading Economics global macro models projections and analysts expectations.

Merit Medical Systems, Inc. designs, develops, manufactures and markets medical products for interventional and diagnostic procedures. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.